Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

Merck & Co. at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Merck & Co. exhibits at Booth 2639 at ASH 2026 in New Orleans. Merck & Co. supports a symposium on myeloproliferative neoplasms, run by Answers in CME. It focuses on turning evidence into action for patients with polycythemia vera and essential thrombocythemia.

OrganizationASH 2026 Attendance
Merck & Co.
Rahway, NJ
merck.com
Large pharma7 exhibitor meeting rooms
Global pharmaceutical company, known as MSD outside the US and Canada, with a broad oncology clinical research program spanning many tumor types.
Booth
Exhibiting at Booth 2639
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
7:00pm–10:00pm
From Evidence to Action in MPNs: Transforming Challenges to Opportunities in PV and ET Patients
Treatment options for polycythemia vera and essential thrombocythemia after first-line therapy fails, including new targeted drugs for patients with unmet needs.
Symposium hosted by Answers in CME
Convention Center · 208-210
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Merck & Co.

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction